Vitamin D Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal Feed, Pharmaceuticals, Food & Beverages, Personal Care, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 123.45 Million
CAGR (2026-2031)	5.65%
Fastest Growing Segment	Direct
Largest Market	North America
Market Size (2031)	USD 171.68 Million

Market Overview

The Global Vitamin D Market is projected to grow from USD 123.45 Million in 2025 to USD 171.68 Million by 2031 at a 5.65% CAGR. The global Vitamin D market encompasses fat-soluble secosteroids vital for calcium absorption, bone metabolism, and immune system function. Market expansion is primarily driven by the escalating global prevalence of vitamin D deficiency, increasing consumer awareness regarding its profound health benefits, and the expanding aging demographic prone to bone-related disorders. According to the Council for Responsible Nutrition (CRN), in 2025, vitamin D was the most popular vitamin or mineral used by U.S. adults, with 48.2% reporting its use, including through multivitamin/multimineral supplements.

A significant challenge impeding market growth is the volatility and limitations within the global supply chain for key raw materials, often leading to price fluctuations and potential product shortages.

Key Market Drivers

Deficiency-driven demand as a primary market driver
The high global prevalence of vitamin D deficiency stands as a primary catalyst for the burgeoning Global Vitamin D Market. A substantial portion of the world's population exhibits insufficient vitamin D levels, leading to widespread health issues ranging from bone disorders to compromised immune function. This deficiency creates an inherent demand for supplementation and fortified products as individuals and healthcare systems seek to mitigate associated risks. According to a study published in the European Journal of Clinical Nutrition in March 2025, in the Czech Republic, the highest vitamin D deficiency prevalence was observed in the 91–100 years age group, at 51.8%, highlighting the significant need within vulnerable populations. This pervasive inadequacy drives both preventative and therapeutic consumption of vitamin D across various demographics.

Expansion of vitamin D applications across products
The broadening of pharmaceutical and dietary supplement applications for vitamin D further propels market expansion, driven by increasing recognition of its diverse health benefits. Manufacturers are continually innovating to meet evolving demands and integrate vitamin D into a wider array of products. In October 2025, BASF, a leading chemical company, launched one new combined vitamin A and D3 product for animal nutrition, demonstrating expanding applications within the animal feed sector. This continuous development and expanded usage in various formulations underscore a robust and diversifying market landscape. Furthermore, the Animal Nutrition & Health business of dsm-firmenich, which includes vitamins, generated approximately €3.5 billion in annualized net sales in 2025, underscoring the substantial commercial activity in this essential nutrient segment.

Download Free Sample Report

Key Market Challenges

The global Vitamin D market faces significant impediment from the volatility and limitations within the global supply chain for key raw materials. This inherent instability often leads to considerable price fluctuations and potential product shortages, directly affecting manufacturers' ability to maintain consistent production and stable pricing for finished goods. Disruptions, such as geopolitical events or logistical challenges, exacerbate these vulnerabilities.

According to Feed Ingredients, in 2026, global supply chains for Vitamin AD3, which includes D3, remain highly concentrated, with over 65% of raw intermediates sourced from a limited group of Asian and European manufacturers. This reliance on a narrow base of suppliers creates a fragile environment where any disruption quickly translates into increased operational costs for producers and higher retail prices for consumers. Such supply chain constraints can also hinder innovation and market responsiveness, as securing new or alternative raw material sources becomes a complex and time-consuming process, thereby impeding overall market growth.

Key Market Trends

The surge in plant-based and vegan vitamin D offerings represents a pivotal market shift driven by evolving consumer dietary preferences and ethical considerations. As more individuals adopt plant-based lifestyles, the demand for non-animal-derived vitamin D sources, such as those obtained from lichen or mushrooms, has significantly increased. This trend compels manufacturers to innovate and diversify their product lines, expanding market accessibility for this growing demographic with tailored solutions. According to IndexBox, in May 2026, in the 'Vegan Vitamin D3 Market in the United States' report, unit sales of Vegan Vitamin D3 supplements across U.S. tracked retail channels grew by an estimated 11–14% year-over-year in 2025. This development underscores a substantial avenue for market growth beyond traditional animal-sourced vitamin D.

Advancements in personalized nutrition combined with digital health integration are fundamentally reshaping how consumers engage with vitamin D supplementation. Leveraging genetic insights, individual lifestyle data, and real-time biometric feedback, digital platforms are now capable of delivering highly customized vitamin D recommendations. This tailored approach moves beyond conventional generalized advice, significantly enhancing consumer adherence and optimizing the efficacy of nutrient management strategies, particularly for specific health needs. In a notable development, according to Foley & Lardner LLP, in January 2026, in their article '5 Developments Digital Health Innovators Should Watch in 2026', over 60 companies pledged to collaborate with the CMS Health Technology Ecosystem initiative in Q1 2026, demonstrating a concerted push toward patient-centric digital health applications. This trend fosters a more precise and impactful method for addressing individual vitamin D requirements within a broader healthcare context.

Segmental Insights

The Direct sales channel is emerging as the fastest-growing segment in the global Vitamin D market. This rapid growth is driven by the demand for products offering controlled dosing and swift absorption, which particularly appeals to consumers seeking immediate health benefits. This is especially significant for vulnerable populations, including the elderly, pregnant women, and individuals with limited sun exposure or malabsorption issues, who require more reliable and potent doses than typically available through fortified foods alone. Furthermore, advancements in delivery technologies, such as sublingual sprays and nanoemulsions, are enhancing bioavailability and supporting the expansion of this segment.

Regional Insights

North America consistently leads the global Vitamin D market, largely due to high consumer awareness, widespread fortification policies, and a robust healthcare infrastructure. The region benefits from strong attention to preventive healthcare, along with routine recommendations for vitamin D testing and supplementation from healthcare professionals across the U.S. and Canada. Additionally, a sophisticated nutraceutical industry and favorable government support for food fortification programs, including progressive Food and Drug Administration guidelines, significantly contribute to North America's market dominance.

Recent Developments

• In December 2025, dsm-firmenich received a new European Union authorization for its Hy-D® vitamin D3 metabolite, expanding its commercial use to all animal species, including salmonids and other aquatic animals. This landmark decision followed confirmation of Hy-D®'s safety and efficacy by the European Food Safety Authority. The innovative metabolite, produced from Saccharomyces cerevisiae, supports optimal levels of 25-OH-D₃, leading to improved animal health, welfare, productivity, and overall food quality. This authorization enhanced access for feed producers and farmers across the EU, furthering advancements in animal nutrition within the global vitamin D market.
• In November 2025, Amway India introduced Nutrilite™ Vitamin D plus Boron to the market. This new formulation combined vitamin D3 and K2, along with boron and quercetin, to address the widespread vitamin D deficiency prevalent in India. The product was designed to help maintain optimal vitamin D levels and support both bone and immune health. This launch represented Amway India's ongoing efforts to provide specialized nutritional supplements, catering to specific health concerns within the global vitamin D market and offering consumers a comprehensive solution for essential nutrient intake.
• In October 2025, BASF launched Lutavit® A/D3 1000/200 NXT, an innovative vitamin formulation for animal nutrition. This new product integrated vitamin A and vitamin D3 into a single, microencapsulated form, signifying BASF's renewed presence in this segment of the market. The formulation provides a consistent 5:1 ratio of vitamin A to D3, making it suitable for various animal species and ensuring superior stability in demanding applications. This introduction reinforced BASF's dedication to delivering high-quality, sustainable, and convenient nutritional solutions, utilizing its expertise in vitamin formulation and production.
• In May 2025, Nutriearth, a producer of natural vitamin D3, announced a new distribution partnership with AIDP Inc. This collaboration aimed to expand the availability of Nutriearth's vitamin D3 oil across North American dietary supplement and nutraceutical markets. The partnership provides manufacturers and brands with increased access to the ingredient. Nutriearth's vitamin D3 is produced using a bioresource, designed to mimic the body's natural synthesis of the vitamin without chemical extraction or solvents. This strategic alliance highlights both companies' commitment to offering sustainable and high-quality vitamin D3 solutions to a broader consumer base.

Key Market Players

• DSM-Firmenich
• BASF SE
• Lonza Group AG
• Fermenta Biotech Limited
• Dishman Carbogen Amcis Ltd.
• Zhejiang Garden Biopharmaceutical Co., Ltd.
• Taizhou Hisound Pharmaceutical Co., Ltd.
• Xiamen Jindawei Group Co., Ltd.
• SternVitamin GmbH & Co. KG
• Divi’s Laboratories Limited

By Sales Channel	By End Use	By Region
Direct Indirect	Animal Feed Pharmaceuticals Food & Beverages Personal Care Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vitamin D Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vitamin D Market, By Sales Channel:

• Direct
• Indirect

• Vitamin D Market, By End Use:

• Animal Feed
• Pharmaceuticals
• Food & Beverages
• Personal Care
• Others

• Vitamin D Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE